To eliminate the possible deviation due to the genetic alterations between different breast cancer cell lines, a pair of isogenic ERα+ BCap-ER /ERα− BCap-V (control) breast cancer cell lines was used. This evidence concerns the gene ESR1 and breast carcinoma.